Pharmacovigilance with Ibrutinib in Chronic Lymphocytic Leukemia
2 Views
administrator
07/14/23
The panelists, Shuo Ma, MD, PhD; Susan M. O’Brien, MD; William G. Wierda, MD, PhD; Alessandra Ferrajoli, MD; Richard R. Furman, MD; and Thomas J. Kipps, MD, PhD, address drug-drug interactions involving ibrutinib in the treatment of chronic lymphocytic leukemia.
Show more
Facebook Comments
No comments found